Estatísticas

	Visualizacións
Very early molecular responses in the first two months of therapy are highly predictive of deep molecular responses at 18 months, in chronic myeloid leukemia patients treated upfront with nilotinib	57

Seleccione un intervalo de tempo:

	Visualizacións
Very early molecular responses in the first two months of therapy are highly predictive of deep molecular responses at 18 months, in chronic myeloid leukemia patients treated upfront with nilotinib	25

O repositorio dixital RUNA